Larvol Delta - Bioequivalence-Phase-I-Study-of-BFI751-Compared-With-EU-and-USSTELARA174-in-Healthy-Adults

Stelara (ustekinumab) - J&J

BFI-751 (ustekinumab biosimilar) - BioFactura

http://clinicaltrials.gov/ct2/show/NCT04843631

Mar 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next